Agenda
We would like to thank our exhibitors and sponsors for sponsoring this meeting which includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.
Monday, November 25, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9:20 AM - 10:15 AM | Chair's opening remarks followed by: Managing pulmonary hypertension as an MDT
David Kiely Consultant Respiratory Physician, Professor of Pulmonary Vascular Medicine, Sheffield Teaching Hospitals NHS Foundation Trust Colm McCabe Respiratory Consultant in Pulmonary Hypertension, Royal Brompton Hospital Heba Nashat Consultant Cardiologist in Pulmonary Hypertension, Royal Brompton Hospital Helena Beer Editor, Hospital Healthcare Europe, Hospital Pharmacy Europe | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10:25 AM - 11:10 AM | Transforming COPD care - optimising COPD maintenance therapy in secondary care: Interventions in secondary care to improve patient outcomes This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11:20 AM - 12:05 PM | Rethinking severe asthma: Innovations in management and patient outcome This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12:05 PM | Chair change over | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12:15 PM - 1:00 PM | Lung cancer – management and diagnosis: NICE guidance
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1:10 PM - 1:55 PM | What should we know about sleep-disordered breathing (SDB)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2:05 PM - 2:55 PM | Severe respiratory disease challenges & management (ERS guideline discussion)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2:50 PM | End of conference |

Dr Alanna Hare
President, British Sleep Society, Treasurer, British Thoracic Society Consultant Physician, Department of Sleep and Ventilation, Royal Brompton and Harefield Hospitals

David Kiely
Consultant Respiratory Physician, Professor of Pulmonary Vascular Medicine, Sheffield Teaching Hospitals NHS Foundation Trust

Ravijyot Saggu
Respiratory and Medicines Optimisation Pharmacist, UKCPA Respiratory Committee Chair, Clinical Member, NHSE Respiratory Clinical Reference Group

Dr Ernie Wong
Consultant Respiratory Physician, Clinical Lead for Asthma, Imperial College Healthcare NHS Trust, Honorary Clinical Senior Lecturer, National Heart and Lung Institute, Imperial College London

President, British Sleep Society, Treasurer, British Thoracic Society Consultant Physician, Department of Sleep and Ventilation, Royal Brompton and Harefield Hospitals

Consultant Respiratory Physician, Professor of Pulmonary Vascular Medicine, Sheffield Teaching Hospitals NHS Foundation Trust

Respiratory and Medicines Optimisation Pharmacist, UKCPA Respiratory Committee Chair, Clinical Member, NHSE Respiratory Clinical Reference Group

Consultant Respiratory Physician, Clinical Lead for Asthma, Imperial College Healthcare NHS Trust, Honorary Clinical Senior Lecturer, National Heart and Lung Institute, Imperial College London